G. Thomas Budd
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Lung Cancer Treatments and Mutations
Most-Cited Works
- → NCCN Guidelines Insights: Bone Cancer, Version 2.2017(2017)293 cited
- → Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: An Integrated Safety Analysis(2014)124 cited
- → Monitoring apoptosis and Bcl‐2 on circulating tumor cells in patients with metastatic breast cancer(2013)100 cited
- → Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer(2011)70 cited
- → Outcome of Patients With Early-Stage Breast Cancer Treated With Doxorubicin-Based Adjuvant Chemotherapy As a Function of HER2 and TOP2A Status(2009)65 cited
- Phase II clinical trial of imatinib mesylate in therapy of KIT and/or PDGFRalpha-expressing Ewing sarcoma family of tumors and desmoplastic small round cell tumors.(2010)
- → Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis(2019)55 cited
- → Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature(2016)52 cited
- → PROSTACYCLIN THERAPY OF THROMBOTIC THROMBOCYTOPENIC PURPURA(1980)49 cited
- → Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer(1995)46 cited